Activation of CCR5 by Chemokines Involves an Aromatic Cluster between Transmembrane Helices 2 and 3*

CCR5 is a G protein-coupled receptor responding to four natural agonists, the chemokines RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein (MIP)-1α, MIP-1β, and monocyte chemotactic protein (MCP)-2, and is the main co-receptor for the macrophage-tropic human immunodeficiency virus strains. We have previously identified a structural motif in the second transmembrane helix of CCR5, which plays a crucial role in the mechanism of receptor activation. We now report the specific role of aromatic residues in helices 2 and 3 of CCR5 in this mechanism. Using site-directed mutagenesis and molecular modeling in a combined approach, we demonstrate that a cluster of aromatic residues at the extracellular border of these two helices are involved in chemokine-induced activation. These aromatic residues are involved in interhelical interactions that are key for the conformation of the helices and govern the functional response to chemokines in a ligand-specific manner. We therefore suggest that transmembrane helices 2 and 3 contain important structural elements for the activation mechanism of chemokine receptors, and possibly other related receptors as well.

[1]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[2]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[3]  T. Steiner,et al.  Hydrogen bonds with pi-acceptors in proteins: frequencies and role in stabilizing local 3D structures. , 2001, Journal of molecular biology.

[4]  H. Guy,et al.  Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.

[5]  D. Missé,et al.  HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. , 2001, Blood.

[6]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[7]  D. Larhammar,et al.  Mutagenesis of the human 5-HT1B receptor: differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction. , 1998, Journal of receptor and signal transduction research.

[8]  Xi-Ping Huang,et al.  Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors , 1999, British journal of pharmacology.

[9]  Shoshana J. Wodak,et al.  The TXP Motif in the Second Transmembrane Helix of CCR5 , 2001, The Journal of Biological Chemistry.

[10]  S. Rees,et al.  A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. , 1997, Analytical biochemistry.

[11]  C. Strader,et al.  The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. , 1994, The Journal of biological chemistry.

[12]  N. Taylor,et al.  Macrophage inflammatory protein-1β induces migration and activation of human thymocytes , 1998 .

[13]  Roger E Bumgarner,et al.  Benzene Forms Hydrogen Bonds with Water , 1992, Science.

[14]  E. Meng,et al.  Receptor activation: what does the rhodopsin structure tell us? , 2001, Trends in pharmacological sciences.

[15]  Lawrence M. Lifshitz,et al.  Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. , 1998, Science.

[16]  Leonardo Pardo,et al.  Influence of the environment in the conformation of alpha-helices studied by protein database search and molecular dynamics simulations. , 2002, Biophysical journal.

[17]  H. Akil,et al.  Hydrophobic Residues of the D2 Dopamine Receptor Are Important for Binding and Signal Transduction , 1995, Journal of neurochemistry.

[18]  Z. Vogel,et al.  Functional Role of Tryptophan Residues in the Fourth Transmembrane Domainof the CB2 Cannabinoid Receptor , 2000, Journal of neurochemistry.

[19]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[20]  Marc Parmentier,et al.  Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. , 2002, Molecular biology of the cell.

[21]  T. Schwartz,et al.  Conserved HisVI‐17 of the NK‐1 receptor is involved in binding of non‐peptide antagonists but not substance P , 1993, FEBS letters.

[22]  L. Kelley,et al.  An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.

[23]  J. Ballesteros,et al.  A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. , 1998, Biochemistry.

[24]  B. Roth,et al.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. , 1997, Molecular pharmacology.

[25]  D. Farrens,et al.  Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.

[26]  S. Cooper,et al.  Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. , 1999, Biochemical and biophysical research communications.

[27]  J. Ballesteros,et al.  Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.

[28]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[29]  M. Scheinin,et al.  Chloroethylclonidine and 2-Aminoethyl Methanethiosulfonate Recognize Two Different Conformations of the Human α2A-Adrenergic Receptor* , 1999, The Journal of Biological Chemistry.

[30]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[31]  Marc Parmentier,et al.  The Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity* , 1997, The Journal of Biological Chemistry.

[32]  C. Strader,et al.  Amino–aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345 , 1993, Nature.

[33]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999 .

[34]  J. Wess,et al.  Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.

[35]  J. Ballesteros,et al.  The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. , 1999, Biophysical journal.

[36]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[37]  R. Doms,et al.  Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways* , 2001, The Journal of Biological Chemistry.

[38]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[39]  J. Wess,et al.  Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.

[40]  G A Petsko,et al.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.

[41]  R. Osman,et al.  A hydrophobic cluster between transmembrane helices 5 and 6 constrains the thyrotropin-releasing hormone receptor in an inactive conformation. , 1998, Molecular pharmacology.

[42]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[43]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[44]  G Vassart,et al.  Extracellular Cysteines of CCR5 Are Required for Chemokine Binding, but Dispensable for HIV-1 Coreceptor Activity* , 1999, The Journal of Biological Chemistry.

[45]  Leonardo Pardo,et al.  Serine and Threonine Residues Bend α-Helices in the χ1 = g− Conformation , 2000 .

[46]  Kazumasa Honda,et al.  The Magnitude of the CH/π Interaction between Benzene and Some Model Hydrocarbons , 2000 .

[47]  H Weinstein,et al.  Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.

[48]  K D Ridge,et al.  Light-induced exposure of the cytoplasmic end of transmembrane helix seven in rhodopsin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Roland L. Dunbrack,et al.  Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.

[50]  T. Bártfai,et al.  Delineation of the peptide binding site of the human galanin receptor. , 1996, The EMBO journal.

[51]  L. Pardo,et al.  Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine(1a) receptor ligands to explore the three-dimensional structure of the receptor. , 2002, Molecular pharmacology.

[52]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .